Works matching IS 03407004 AND DT 2015 AND VI 64 AND IP 12

Results: 12

RNA and protein expression of herpesvirus entry mediator (HVEM) is associated with molecular markers, immunity-related pathways and relapse-free survival of patients with AML.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 12, p. 1505, doi. 10.1007/s00262-015-1755-8

By:

Lichtenegger, Felix;
Kondla, Isabell;
Krempasky, Michael;
Weber, Anna;
Herold, Tobias;
Krupka, Christina;
Spiekermann, Karsten;
Schneider, Stephanie;
Büchner, Thomas;
Berdel, Wolfgang;
Wörmann, Bernhard;
Hiddemann, Wolfgang;
Subklewe, Marion

Publication type:

Article

Haptoglobin promoter polymorphism rs5472 as a prognostic biomarker for peptide vaccine efficacy in castration-resistant prostate cancer patients.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 12, p. 1565, doi. 10.1007/s00262-015-1756-7

By:

Araki, Hiromitsu;
Pang, Xiaoliang;
Komatsu, Nobukazu;
Soejima, Mikiko;
Miyata, Nawoe;
Takaki, Mari;
Muta, Shigeru;
Sasada, Tetsuro;
Noguchi, Masanori;
Koda, Yoshiro;
Itoh, Kyogo;
Kuhara, Satoru;
Tashiro, Kosuke

Publication type:

Article

Modification of cytokine-induced killer cells with chimeric antigen receptors (CARs) enhances antitumor immunity to epidermal growth factor receptor (EGFR)-positive malignancies.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 12, p. 1517, doi. 10.1007/s00262-015-1757-6

By:

Ren, Xuequn;
Ma, Wanli;
Lu, Hong;
Yuan, Lei;
An, Lei;
Wang, Xicai;
Cheng, Guanchang;
Zuo, Shuguang

Publication type:

Article

Defining the effects of age and gender on immune response and outcomes to melanoma vaccination: a retrospective analysis of a single-institution clinical trials' experience.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 12, p. 1531, doi. 10.1007/s00262-015-1758-5

By:

Ramirez, Adriana;
Wages, Nolan;
Hu, Yinin;
Smolkin, Mark;
Slingluff, Craig

Publication type:

Article

Late administration of murine CTLA-4 blockade prolongs CD8-mediated anti-tumor effects following stimulatory cancer immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 12, p. 1541, doi. 10.1007/s00262-015-1759-4

By:

Sckisel, Gail;
Mirsoian, Annie;
Bouchlaka, Myriam;
Tietze, Julia;
Chen, Mingyi;
Blazar, Bruce;
Murphy, William

Publication type:

Article

Downstream mediators of the intratumoral interferon response suppress antitumor immunity, induce gemcitabine resistance and associate with poor survival in human pancreatic cancer.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 12, p. 1553, doi. 10.1007/s00262-015-1760-y

By:

Delitto, Daniel;
Perez, Chelsey;
Han, Song;
Gonzalo, David;
Pham, Kien;
Knowlton, Andrea;
Graves, Christina;
Behrns, Kevin;
Moldawer, Lyle;
Thomas, Ryan;
Liu, Chen;
George, Thomas;
Trevino, Jose;
Wallet, Shannon;
Hughes, Steven

Publication type:

Article

Novel angiogenin mutants with increased cytotoxicity enhance the depletion of pro-inflammatory macrophages and leukemia cells ex vivo.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 12, p. 1575, doi. 10.1007/s00262-015-1763-8

By:

Cremer, Christian;
Braun, Hanna;
Mladenov, Radoslav;
Schenke, Lea;
Cong, Xiaojing;
Jost, Edgar;
Brümmendorf, Tim;
Fischer, Rainer;
Carloni, Paolo;
Barth, Stefan;
Nachreiner, Thomas

Publication type:

Article

Increased tumor infiltration by mucosal-associated invariant T cells correlates with poor survival in colorectal cancer patients.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 12, p. 1601, doi. 10.1007/s00262-015-1764-7

By:

Zabijak, Luciane;
Attencourt, Christophe;
Guignant, Caroline;
Chatelain, Denis;
Marcelo, Paulo;
Marolleau, Jean-Pierre;
Treiner, Emmanuel

Publication type:

Article

Myeloid-derived suppressor cells inhibit T cell proliferation in human extranodal NK/T cell lymphoma: a novel prognostic indicator.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 12, p. 1587, doi. 10.1007/s00262-015-1765-6

By:

Zhang, Han;
Li, Ze-Lei;
Ye, Shu-Biao;
Ouyang, Li-Ying;
Chen, Yu-Shan;
He, Jia;
Huang, Hui-Qiang;
Zeng, Yi-Xin;
Zhang, Xiao-Shi;
Li, Jiang

Publication type:

Article

Immunological factors influencing clinical outcome in lung cancer patients after telomerase peptide vaccination.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 12, p. 1609, doi. 10.1007/s00262-015-1766-5

By:

Hansen, Gaute;
Gaudernack, Gustav;
Brunsvig, Paal;
Cvancarova, Milada;
Kyte, Jon

Publication type:

Article

Stability and activity of MCSP-specific chimeric antigen receptors (CARs) depend on the scFv antigen-binding domain and the protein backbone.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 12, p. 1623, doi. 10.1007/s00262-015-1767-4

By:

Krug, Christian;
Birkholz, Katrin;
Paulus, Alexander;
Schwenkert, Michael;
Schmidt, Patrick;
Hoffmann, Nicole;
Hombach, Andreas;
Fey, Georg;
Abken, Hinrich;
Schuler, Gerold;
Schuler-Thurner, Beatrice;
Dörrie, Jan;
Schaft, Niels

Publication type:

Article

Regulatory T cells, inherited variation, and clinical outcome in epithelial ovarian cancer.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 12, p. 1495, doi. 10.1007/s00262-015-1753-x

By:

Knutson, Keith;
Maurer, Matthew;
Preston, Claudia;
Moysich, Kirsten;
Goergen, Krista;
Hawthorne, Kieran;
Cunningham, Julie;
Odunsi, Kunle;
Hartmann, Lynn;
Kalli, Kimberly;
Oberg, Ann;
Goode, Ellen

Publication type:

Article